Organogenesis Holdings Inc (ORGO)
2.28
-0.03
(-1.30%)
USD |
NASDAQ |
May 09, 16:00
2.28
0.00 (0.00%)
After-Hours: 17:14
Organogenesis Holdings Revenue (Quarterly): 99.65M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 99.65M |
September 30, 2023 | 108.53M |
June 30, 2023 | 117.32M |
March 31, 2023 | 107.64M |
December 31, 2022 | 115.52M |
September 30, 2022 | 116.86M |
June 30, 2022 | 121.40M |
March 31, 2022 | 97.12M |
December 31, 2021 | 127.86M |
September 30, 2021 | 113.75M |
June 30, 2021 | 123.20M |
March 31, 2021 | 102.55M |
December 31, 2020 | 106.81M |
September 30, 2020 | 100.80M |
June 30, 2020 | 68.96M |
Date | Value |
---|---|
March 31, 2020 | 61.73M |
December 31, 2019 | 74.64M |
September 30, 2019 | 64.26M |
June 30, 2019 | 64.95M |
March 31, 2019 | 57.12M |
December 31, 2018 | 63.60M |
September 30, 2018 | 50.77M |
June 30, 2018 | 43.55M |
March 31, 2018 | 35.53M |
December 31, 2017 | 198.51M |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | 138.73M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
61.73M
Minimum
Mar 2020
127.86M
Maximum
Dec 2021
99.66M
Average
106.81M
Median
Dec 2020
Revenue (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.727M |
Palatin Technologies Inc | 2.034M |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -0.568M |
Total Expenses (Quarterly) | 100.92M |
EPS Diluted (Quarterly) | -0.0043 |
Enterprise Value | 267.23M |
Gross Profit Margin (Quarterly) | 72.13% |
Profit Margin (Quarterly) | -0.57% |
Earnings Yield | 1.56% |
Operating Earnings Yield | 4.14% |
Normalized Earnings Yield | 1.564 |